Avedro Introduces KXL II and Adds to it's Riboflavin Line

posted Jul 5, 2014, 5:36 PM by Jen Weigel
Two "recent" announcements by Avedro have been made.  I say "recent" because it's been a while since I've made posts, so I'm catching up here.

First, at the end of April, Avedro received Candadian approval for KXL II ™ Advanced Cross-Linking System.  This was the first that I'd heard of the KXL II process.  Basically, it allows for a procedure called PiXL™ (Photorefractive Intrastromal Cross-Linking).  Now, I have to admit that the news brief about it didn't really make much sense to me, so I asked Avedro for more information.  From what I can understand since I didn't have many resources on this topic, PiXL allows one to control the amount of cross-linking done in specific areas of the cornea, and this selective cross-linking can correct vision without having to use an excimer laser.  Now, don't quote me on this.  I'm supposing that we'll learn more about this in due time.

In June, Avedro expanded its presence in the riboflavin supply market.  Who knew there were that many suppliers of riboflavin?  In re-reading this press release today, I did have to chuckle when I read the following line:  "David Muller, PhD, CEO of Avedro commented, 'I am extremely pleased to have consummated this important transaction with Medio-Haus.'"  Hmm ... consummated?  I think the use of a thesaurus should come with a warning for some users.  Or, where was his editor?  - jw